Company / Current Assets per Share
Kymera Therapeutics, Inc. Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$13.43
FY2025
5-year range
$8.14 / $13.43
FY2021-FY2025
Trend
+46.3%
vs FY2024
Sector context
#50 of 210
Health Care
What the data says
Kymera Therapeutics, Inc.'s current assets per share of $13.43 is higher than 76% of companies in the Health Care sector (FY2025). Current Assets per Share has increased for 3 consecutive years, from $8.14 in FY2022 to $13.43 in FY2025.
Based on SEC 10-K filings.
13.43 in FY2025 with a 5-year CAGR of -38.8%. Top quartile in the Health Care sector.
Improved from $8.45 to $13.43 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +18.2%
- 5-Year CAGR
- -38.8%
- 10-Year CAGR
- -
Sector benchmark
-90.0% below sector average
Key checks
Key Insights
- Kymera Therapeutics, Inc.'s current assets per share has grown for 3 consecutive years.
- In FY2025, current assets per share increased 46.3% year-over-year.
- Ranks #50 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.43 | +46.3% |
| FY2024 | $9.18 | +8.7% |
| FY2023 | $8.45 | +3.8% |
| FY2022 | $8.14 | -19.8% |
| FY2021 | $10.15 | -93.5% |
| FY2020 | $156.69 | +186.7% |
| FY2019 | $54.66 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026